Ocrelizumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Genentech brand Hoffmann-La Roche brand owl:NamedIndividual Monoclonal antibody Therapeutic monoclonal antibody Drug granted breakthrough therapy designation
rdfs:label	Ocrelizumab
owl:sameAs	dbr:Ocrelizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Roche http://en.wikipedia.org/wiki/Genentech http://en.wikipedia.org/wiki/Multiple_sclerosis_drug_pipeline http://en.wikipedia.org/wiki/List_of_drugs:_O%E2%80%93Op http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/First-in-class_medication http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Genentech_brands http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands http://en.wikipedia.org/wiki/Rituximab
skos:prefLabel	Ocrelizumab
skos:altLabel	Ocrevus Ocrevus® ocrelizumab
clgo:alternativeName	Ocrevus
clgo:casNumber	637334-45-3
clgo:drugbank	DB11988
clgo:fdaUniiCode	A10SJL62JY
clgo:kegg	D05218
clgo:medlinePlus	a617026
is clgo:product of	Genentech

About: clgr:Ocrelizumab